The commonly used 20-minute icing protocol may underdeliver deep cooling and contribute to nocebo-related pain amplification after orthopedic and spinal surgery: a biophysical perspective.
文献摘要
Background A distinct nocebo pathway - treatment delivery failure as a generator of expectation violation and pain amplification - has received little attention despite its ubiquity in post-operative orthopedic and spinal care. Argument Cold application activates cutaneous TRPM8 receptors at temperatures below 25°C, producing genuine but modest skin-surface analgesia. However, a commonly used 20-minute icing limit in standard discharge instructions reflects frostbite prevention considerations rather than a therapeutically derived dose. In experimental studies, deeper tissue temperatures often continued to decline beyond 20 minutes of surface cooling, with substantial reductions reported during applications of 30-45 minutes, consistent with heat diffusion through tissue opposed by blood perfusion. The resulting gap between modest cutaneous analgesia and expected surgical-site relief may generate accurate negative outcome expectations of inadequate treatment effect. Conditioned through repeated applications and resistant to extinction under partial reinforcement, this delivery-failure nocebo cycle may compound the direct insufficiency of cold therapy and erode engagement with broader non-pharmacological recovery strategies. Conclusion Delivery-failure nocebo is a potentially actionable nocebo risk category, distinct from explicit verbal suggestion-mediated induction, requiring empirical verification. Correction may require improving cold therapy delivery through mechanisms not constrained by the frostbite risk of passive cold media - potentially restoring the expectation-amplified analgesic benefit that adequate cold therapy can produce - and modifying clinician communication to accurately frame the 20-minute limit as a frostbite precaution, not a therapeutic dose.